Inhibitor Therapeutics, Inc. (INTI) stock
INTIOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.11+0.00 (+0.09%)
Close on Oct 19, 2026Market cap $19.06MP/E –Yield –
Inhibitor Therapeutics cash
Cash and short-term investments held at the end of each period.
Inhibitor Therapeutics's cash was $515.76K at Jun 30, 2026. For fiscal 2025 it was $2.38M, down 57.6% from the year before. Over ten years it grew 14.7% a year on average. The highest annual figure on record is $11.95M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.38M | -57.6% |
| FY2024 | Dec 31, 2024 | $5.61M | -36.6% |
| FY2023 | Dec 31, 2023 | $8.84M | -26.0% |
| FY2022 | Dec 31, 2022 | $11.95M | +38923.1% |
| FY2021 | Dec 31, 2021 | $30.63K | -59.2% |
| FY2020 | Dec 31, 2020 | $75.06K | -90.7% |
| FY2019 | Dec 31, 2019 | $803.82K | -27.5% |
| FY2018 | Dec 31, 2018 | $1.11M | +222.2% |
| FY2017 | Dec 31, 2017 | $344.11K | -95.0% |
| FY2016 | Dec 31, 2016 | $6.89M | +1044.8% |
| FY2015 | Dec 31, 2015 | $601.45K | +64.7% |
| FY2014 | Dec 31, 2014 | $365.16K | +168177.0% |
| FY2013 | Dec 31, 2013 | $217 | -100.0% |
| FY2012 | Dec 31, 2012 | $857.70K | -35.1% |
| FY2011 | Dec 31, 2011 | $1.32M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $515.76K | -86.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.29M | -70.1% |
| Q4 FY2025 | Dec 31, 2025 | $2.38M | -57.6% |
| Q3 FY2025 | Sep 30, 2025 | $2.98M | -53.3% |
| Q2 FY2025 | Jun 30, 2025 | $3.74M | -47.3% |
| Q1 FY2025 | Mar 31, 2025 | $4.32M | -43.7% |
| Q4 FY2024 | Dec 31, 2024 | $5.61M | -36.6% |
| Q3 FY2024 | Sep 30, 2024 | $6.38M | -33.1% |
| Q2 FY2024 | Jun 30, 2024 | $7.10M | -29.7% |
| Q1 FY2024 | Mar 31, 2024 | $7.68M | -28.8% |
| Q4 FY2023 | Dec 31, 2023 | $8.84M | -26.0% |
| Q3 FY2023 | Sep 30, 2023 | $9.54M | +17875.8% |
| Q2 FY2023 | Jun 30, 2023 | $10.10M | +40390.4% |
| Q1 FY2023 | Mar 31, 2023 | $10.78M | +29492.6% |
| Q4 FY2022 | Dec 31, 2022 | $11.95M | +38923.1% |
| Q3 FY2022 | Sep 30, 2022 | $53.06K | -0.4% |
| Q2 FY2022 | Jun 30, 2022 | $24.95K | -73.4% |
| Q1 FY2022 | Mar 31, 2022 | $36.44K | -56.7% |
| Q4 FY2021 | Dec 31, 2021 | $30.63K | -59.2% |
| Q3 FY2021 | Sep 30, 2021 | $53.29K | +45.2% |
| Q2 FY2021 | Jun 30, 2021 | $93.72K | -31.8% |
| Q1 FY2021 | Mar 31, 2021 | $84.19K | -72.2% |
| Q4 FY2020 | Dec 31, 2020 | $75.06K | -90.7% |
| Q3 FY2020 | Sep 30, 2020 | $36.71K | -97.3% |
| Q2 FY2020 | Jun 30, 2020 | $137.32K | -93.2% |
| Q1 FY2020 | Mar 31, 2020 | $302.69K | -73.2% |
| Q4 FY2019 | Dec 31, 2019 | $803.82K | -27.5% |
| Q3 FY2019 | Sep 30, 2019 | $1.37M | -4.8% |
| Q2 FY2019 | Jun 30, 2019 | $2.03M | +154.5% |
| Q1 FY2019 | Mar 31, 2019 | $1.13M | -28.1% |
| Q4 FY2018 | Dec 31, 2018 | $1.11M | +222.2% |
| Q3 FY2018 | Sep 30, 2018 | $1.44M | +62.4% |
| Q2 FY2018 | Jun 30, 2018 | $795.76K | -51.6% |
| Q1 FY2018 | Mar 31, 2018 | $1.57M | -32.8% |
| Q4 FY2017 | Dec 31, 2017 | $344.11K | -95.0% |
| Q3 FY2017 | Sep 30, 2017 | $887.36K | -75.0% |
| Q2 FY2017 | Jun 30, 2017 | $1.64M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.89M | – |
| Q3 FY2016 | Sep 30, 2016 | $3.55M | – |
See a number that looks wrong?